Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial Flutter
Clinical trial NCT01229254 · COMPLETED
Trial details
- NCT number
- NCT01229254
- Sponsor
- Portola Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2010-12-01
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.